sodium semaglutide Oral Semaglutide, the First Ingestible Glucagon-Like Peptide-1 Receptor Agonist: Could It Be a Magic Bullet for Type 2 Diabetes? Semaglutide delivery excipient Salcaprozate Sodium

Glucagon-like peptide-1 (GLP-1) analog liraglutide inhibits endothelial cell inflammation through a calcium and AMPK dependent mechanism

The FDA has allowed compounding of semaglutide during periods of drug shortage, and many compounding pharmacies have been producing it under these guidelines

Both medications are GLP-1 agonists that help regulate blood sugar and can aid in weight loss

The most common issues are nausea, vomiting, diarrhea, and constipation

If the nausea lasts too long or gets severe, it can impact your daily life

But for millions of people already weighing whether to start a GLP-1 drug for diabetes, obesity or another approved indication, it is one more factor worth considering